Drugs that both activate and block the GIP receptor reduce weight through different brain mechanisms, offering a new ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Citi launched its coverage of Structure Therapeutics with a Buy recommendation and a $60 per share target on Friday, citing ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

The Italian Medicines Agency is ready to evaluate the reimbursement of new drugs against obesity, following the British model ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

Amid new Canadian guidelines suggesting GLP-1 medication for obese kids and teens, dietitians say there are better ways ...